NCT00515684撤回不适用
Corneal Thinning During Topical Bevacizumab Therapy
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •clinical diagnosis of corneal neovascularization
- •must be able to apply eyedrop
排除标准
- •have active keratitis
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
2 期
Bevacizumab for the Treatment of Corneal NeovascularizationCorneal NeovascularizationNCT00992849Chang Gung Memorial Hospital10
已完成
2 期
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCorneal NeovascularizationNCT00555594Asociación para Evitar la Ceguera en México18
已完成
1 期
Topical Avastin for Treatment of Corneal NeovascularizationCorneal NeovascularizationNCT00559936Massachusetts Eye and Ear Infirmary24
已完成
不适用
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCorneal NeovascularizationNCT00512876Walter Reed Army Medical Center24
已完成
3 期
Topical Bevacizumab for Preventing Recurrent PterygiumBevacizumabVEGFAnti-VEGFPterygiumNCT01311960Chulalongkorn University24